MicroRNAs as Oncogenes and Tumor Suppressors

MicroRNAs in Medicine

Volumn , Issue , 2013, Pages 223-243

  Rufino Palomares, Eva E ^a   Reyes Zurita, Fernando J ^a   Lupiáñez, Jose Antonio ^a   Medina, Pedro P ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b PTS Granada   (Spain)

Author keywords

Cancer; MicroRNAs; MiRNAs

Indexed keywords

EID: 85017611131     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118300312.ch14     Document Type: Chapter

References (145)

1. Akao, Y., Y. Nakagawa, and T. Naoe. 2006. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29:903-906.
2. Aravin, A., D. Gaidatzis, S. Pfeffer, M. Lagos-Quintana, P. Landgraf, N. Iovino, P. Morris, M.J. Brownstein, S. Kuramochi-Miyagawa, T. Nakano, M. Chien, J.J. Russo, et al. 2006. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 442:203-207.
3. Babar, I.A., C.J. Cheng, C.J. Booth, X. Liang, J.B. Weidhaas, W.M. Saltzman, and F.J. Slack. 2012. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A 109:E1695-E1704.
4. Baek, D., J. Villén, C. Shin, F.D. Camargo, S.P. Gygi, and D.P. Bartel. 2008. The impact of microRNAs on protein output. Nature 455:64-71.
5. Bartel, D.P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
6. Bommer, G.T., I. Gerin, Y. Feng, A.J. Kaczorowski, R. Kuick, R.E. Love, Y. Zhai, T.J. Giordano, Z.S. Qin, B.B. Moore, O.A. MacDougald, K.R. Cho, et al. 2007. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17:1298-1307.
7. Bueno, M.J., I. Perez de Castro, M. Gomez de Cedron, J. Santos, G.A. Calin, J.C. Cigudosa, C.M. Croce, J. Fernandez-Piqueras, and M. Malumbres. 2008. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13:496-506.
8. Bullrich, F., H. Fujii, G. Calin, H. Mabuchi, M. Negrini, Y. Pekarsky, L. Rassenti, H. Alder, J.C. Reed, M.J. Keating, T.J. Kipps, and C.M. Croce. 2001. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 61:6640-6648.
9. Calin, G.A., C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, et al. 2002. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524-15529.
10. Calin, G.A., C. Sevignani, C.D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini, and C.M. Croce. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:2999-3004.
11. Calin, G.A., M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, S.E. Wojcik, M.V. Iorio, R. Visone, N.I. Sever, M. Fabbri, R. Iuliano, T. Palumbo, et al. 2005. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801.
12. Callegari, E., B.K. Elamin, F. Giannone, M. Milazzo, G. Altavilla, F. Fornari, L. Giacomelli, L. D'Abundo, M. Ferracin, C. Bassi, B. Zagatti, F. Corra, et al. 2012. Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 56:1025-1033.
13. Cervigne, N.K., P.P. Reis, J. Machado, B. Sadikovic, G. Bradley, N.N. Galloni, M. Pintilie, I. Jurisica, B. Perez-Ordonez, R. Gilbert, P. Gullane, J. Irish, et al. 2009. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Human Mol Genet 18:4818-4829.
14. Chan, J.A., A.M. Krichevsky, and K.S. Kosik. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033.
15. Chang, T.C. and J.T. Mendell. 2007. MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8:215-239.
16. Chang, T.C., E.A. Wentzel, O.A. Kent, K. Ramachandran, M. Mullendore, K.H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C.J. Lowenstein, D.E. Arking, M.A. Beer, et al. 2007. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26:745-752.
17. Chang, S.S., W.W. Jiang, I. Smith, L.M. Poeta, S. Begum, C. Glazer, S. Shan, W. Westra, D. Sidransky, and J.A. Califano. 2008a. MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123:2791-2797.
18. Chang, T.C., D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, K.M. West, C.V. Dang, A. Thomas-Tikhonenko, and J.T. Mendell. 2008b. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40:43-50.
19. Chi, S.W., G.J. Hannon, and R.B. Darnell. 2012. An alternative mode of microRNA target recognition. Nat Struct Mol Biol 19:321-327.
20. Christoffersen, N.R., R. Shalgi, L.B. Frankel, E. Leucci, M. Lees, M. Klausen, Y. Pilpel, F.C. Nielsen, M. Oren, and A.H. Lund. 2010. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 17:236-245.
21. Ciafre, S.A., S. Galardi, A. Mangiola, M. Ferracin, C.G. Liu, G. Sabatino, M. Negrini, G. Maira, C.M. Croce, and M.G. Farace. 2005a. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351-1358.
22. Ciafre, S.A., S. Galardi, A. Mangiola, M. Ferracin, C.G. Liu, G. Sabatino, M. Negrini, G. Maira, C.M. Croce, and M.G. Farace. 2005b. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351-1358.
23. Cimmino, A., G.A. Calin, M. Fabbri, M.V. Iorio, M. Ferracin, M. Shimizu, S.E. Wojcik, R.I. Aqeilan, S. Zupo, M. Dono, L. Rassenti, H. Alder, et al. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102:13944-13949.
24. Clurman, B.E. and W.S. Hayward. 1989. Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol 9:2657-2664.
25. Consortium, E.P., B.E. Bernstein, E. Birney, I. Dunham, E.D. Green, C. Gunter, and M. Snyder. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74.
26. Corney, D.C., A. Flesken-Nikitin, A.K. Godwin, W. Wang, and A.Y. Nikitin. 2007. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67:8433-8438.
27. Corsten, M.F., R. Miranda, R. Kasmieh, A.M. Krichevsky, R. Weissleder, and K. Shah. 2007. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67:8994-9000.
28. Costinean, S., N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, N. Heerema, and C.M. Croce. 2006. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 103:7024-7029.
29. Craig, V.J., S.B. Cogliatti, J. Imig, C. Renner, S. Neuenschwander, H. Rehrauer, R. Schlapbach, S. Dirnhofer, A. Tzankov, and A. Muller. 2011. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood 117:6227-6236.
30. Dews, M., A. Homayouni, D. Yu, D. Murphy, C. Sevignani, E. Wentzel, E.E. Furth, W.M. Lee, G.H. Enders, J.T. Mendell, and A. Thomas-Tikhonenko. 2006. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38:1060-1065.
31. Eis, P.S., W. Tam, L. Sun, A. Chadburn, Z. Li, M.F. Gomez, E. Lund, and J.E. Dahlberg. 2005. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102:3627-3632.
32. Fabbri, M., R. Garzon, A. Cimmino, Z. Liu, N. Zanesi, E. Callegari, S. Liu, H. Alder, S. Costinean, C. Fernandez-Cymering, S. Volinia, G. Guler, et al. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104:15805-15810.
33. Felicetti, F., M.C. Errico, L. Bottero, P. Segnalini, A. Stoppacciaro, M. Biffoni, N. Felli, G. Mattia, M. Petrini, M.P. Colombo, C. Peschle, and A. Care. 2008. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68:2745-2754.
34. Feng, R., X. Chen, Y. Yu, L. Su, B. Yu, J. Li, Q. Cai, M. Yan, B. Liu, and Z. Zhu. 2010. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298:50-63.
35. Fornari, F., L. Gramantieri, M. Ferracin, A. Veronese, S. Sabbioni, G.A. Calin, G.L. Grazi, C. Giovannini, C.M. Croce, L. Bolondi, and M. Negrini. 2008. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27:5651-5661.
36. Friedman, R.C., K.K.-H. Farh, C.B. Burge, and D.P. Bartel. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105.
37. Fulci, V., S. Chiaretti, M. Goldoni, G. Azzalin, N. Carucci, S. Tavolaro, L. Castellano, A. Magrelli, F. Citarella, M. Messina, R. Maggio, N. Peragine, et al. 2007. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109:4944-4951.
38. Furuta, M., K.I. Kozaki, S. Tanaka, S. Arii, I. Imoto, and J. Inazawa. 2010. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31:766-776.
39. Garofalo, M., G. Di Leva, G. Romano, G. Nuovo, S.S. Suh, A. Ngankeu, C. Taccioli, F. Pichiorri, H. Alder, P. Secchiero, P. Gasparini, A. Gonelli, et al. 2009. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16:498-509.
40. Garzon, R., C.E. Heaphy, V. Havelange, M. Fabbri, S. Volinia, T. Tsao, N. Zanesi, S.M. Kornblau, G. Marcucci, G.A. Calin, M. Andreeff, and C.M. Croce. 2009. MicroRNA 29b functions in acute myeloid leukemia. Blood 114:5331-5341.
41. Gibcus, J.H., L.P. Tan, G. Harms, R.N. Schakel, D. de Jong, T. Blokzijl, P. Moller, S. Poppema, B.J. Kroesen, and A. van den Berg. 2009. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 11:167-176.
42. Gironella, M., M. Seux, M.J. Xie, C. Cano, R. Tomasini, J. Gommeaux, S. Garcia, J. Nowak, M.L. Yeung, K.T. Jeang, A. Chaix, L. Fazli, et al. 2007. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A 104:16170-16175.
43. Gleave, M.E. and B.P. Monia. 2005. Antisense therapy for cancer. Nat Rev Cancer 5:468-479.
44. Gotte, M., C. Mohr, C.Y. Koo, C. Stock, A.K. Vaske, M. Viola, S.A. Ibrahim, S. Peddibhotla, Y.H. Teng, J.Y. Low, K. Ebnet, L. Kiesel, et al. 2010. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 29:6569-6580.
45. Greither, T., L.F. Grochola, A. Udelnow, C. Lautenschlager, P. Wurl, and H. Taubert. 2010. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126:73-80.
46. Grimson, A., K.K. Farh, W.K. Johnston, P. Garrett-Engele, L.P. Lim, and D.P. Bartel. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91-105.
47. Hamada, S., K. Satoh, W. Fujibuchi, M. Hirota, A. Kanno, J. Unno, A. Masamune, K. Kikuta, K. Kume, and T. Shimosegawa. 2012. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res 10:3-10.
48. Hanahan, D. and R.A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
49. Hatley, M.E., D.M. Patrick, M.R. Garcia, J.A. Richardson, R. Bassel-Duby, E.V. Rooij, and E.N. Olson. 2010. Modulation of K-ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18:282-293.
50. He, L., J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, and S.M. Hammond. 2005. A microRNA polycistron as a potential human oncogene. Nature 435:828-833.
51. He, L., X. He, L.P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, A.L. Jackson, P.S. Linsley, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134.
52. Hermeking, H. 2010. The miR-34 family in cancer and apoptosis. Cell Death Differ 17:193-199.
53. Hill, D.A., J. Ivanovich, J.R. Priest, C.A. Gurnett, L.P. Dehner, D. Desruisseau, J.A. Jarzembowski, K.A. Wikenheiser-Brokamp, B.K. Suarez, A.J. Whelan, G. Williams, D. Bracamontes, et al. 2009. DICER1 mutations in familial pleuropulmonary blastoma. Science 325:965.
54. Ikenaga, N., K. Ohuchida, K. Mizumoto, J. Yu, T. Kayashima, H. Sakai, H. Fujita, K. Nakata, and M. Tanaka. 2010. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol 17:3120-3128.
55. Ishihara, K., D. Sasaki, K. Tsuruda, N. Inokuchi, K. Nagai, H. Hasegawa, K. Yanagihara, and S. Kamihira. 2012. Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia. Cancer Epidemiol 36:560-565.
56. John, B., A.J. Enright, A. Aravin, T. Tuschl, C. Sander, and D.S. Marks. 2004. Human microRNA targets. PLoS Biol 2:e363.
57. Johnson, S.M., H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K.L. Reinert, D. Brown, and F.J. Slack. 2005. RAS is regulated by the let-7 microRNA family. Cell 120:635-647.
58. Johnson, C.D., A. Esquela-Kerscher, G. Stefani, M. Byrom, K. Kelnar, D. Ovcharenko, M. Wilson, X. Wang, J. Shelton, J. Shingara, L. Chin, D. Brown, et al. 2007. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67:7713-7722.
59. Jongen-Lavrencic, M., S.M. Sun, M.K. Dijkstra, P.J. Valk, and B. Lowenberg. 2008. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111:5078-5085.
60. Kanellopoulou, C., S.A. Muljo, A.L. Kung, S. Ganesan, R. Drapkin, T. Jenuwein, D.M. Livingston, and K. Rajewsky. 2005. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19:489-501.
61. Karube, Y., H. Tanaka, H. Osada, S. Tomida, Y. Tatematsu, K. Yanagisawa, Y. Yatabe, J. Takamizawa, S. Miyoshi, T. Mitsudomi, and T. Takahashi. 2005. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96:111-115.
62. Kasinski, A.L. and F.J. Slack. 2012. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res 72:5576-5587.
63. Kawai, S. and A. Amano. 2012. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J Cell Biol 197:201-208.
64. Klein, U., M. Lia, M. Crespo, R. Siegel, Q. Shen, T. Mo, A. Ambesi-Impiombato, A. Califano, A. Migliazza, G. Bhagat, and R. Dalla-Favera. 2010. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17:28-40.
65. Kluiver, J., S. Poppema, D. de Jong, T. Blokzijl, G. Harms, S. Jacobs, B.J. Kroesen, and A. van den Berg. 2005. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207:243-249.
66. Koesters, R., V. Adams, D. Betts, R. Moos, M. Schmid, A. Siermann, S. Hassam, S. Weitz, P. Lichter, P.U. Heitz, M. von Knebel Doeberitz, and J. Briner. 1999. Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34-p35, and expression. Genomics 61:210-218.
67. Krek, A., D. Grun, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. MacMenamin, I. da Piedade, K.C. Gunsalus, M. Stoffel, and N. Rajewsky. 2005. Combinatorial microRNA target predictions. Nat Genet 37:495-500.
68. Kumar, M.S., J. Lu, K.L. Mercer, T.R. Golub, and T. Jacks. 2007. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39:673-677.
69. Kumar, M.S., S.J. Erkeland, R.E. Pester, C.Y. Chen, M.S. Ebert, P.A. Sharp, and T. Jacks. 2008. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 105:3903-3908.
70. Lawrie, C.H., S. Soneji, T. Marafioti, C.D. Cooper, S. Palazzo, J.C. Paterson, H. Cattan, T. Enver, R. Mager, J. Boultwood, J.S. Wainscoat, and C.S. Hatton. 2007. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121:1156-1161.
71. Lee, Y.S. and A. Dutta. 2007. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21:1025-1030.
72. Lee, R.C., R.L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.
73. le Sage, C., R. Nagel, D.A. Egan, M. Schrier, E. Mesman, A. Mangiola, C. Anile, G. Maira, N. Mercatelli, S.A. Ciafre, M.G. Farace, and R. Agami. 2007. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708.
74. Lewis, B.P., C.B. Burge, and D.P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
75. Li, J., H. Huang, L. Sun, M. Yang, C. Pan, W. Chen, D. Wu, Z. Lin, C. Zeng, Y. Yao, P. Zhang, and E. Song. 2009. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15:3998-4008.
76. Li, X.M., A.M. Wang, J. Zhang, and H. Yi. 2011. Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol 28:1054-1057.
77. Lia, M., A. Carette, H. Tang, Q. Shen, T. Mo, G. Bhagat, R. Dalla-Favera, and U. Klein. 2012. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 119:2981-2990.
78. Linsley, P.S., J. Schelter, J. Burchard, M. Kibukawa, M.M. Martin, S.R. Bartz, J.M. Johnson, J.M. Cummins, C.K. Raymond, H. Dai, N. Chau, M. Cleary, et al. 2007. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27:2240-2252.
79. Liu, C.G., G.A. Calin, B. Meloon, N. Gamliel, C. Sevignani, M. Ferracin, C.D. Dumitru, M. Shimizu, S. Zupo, M. Dono, H. Alder, F. Bullrich, et al. 2004. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101:9740-9744.
80. Liu, X., Y. Sun, J. Guo, H. Ma, J. Li, B. Dong, G. Jin, J. Zhang, J. Wu, L. Meng, and C. Shou. 2006. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int J Cancer 118:1922-1929.
81. Liu, Q., H. Fu, F. Sun, H. Zhang, Y. Tie, J. Zhu, R. Xing, Z. Sun, and X. Zheng. 2008. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36:5391-5404.
82. Liu, B., X.C. Peng, X.L. Zheng, J. Wang, and Y.W. Qin. 2009. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66:169-175.
83. Lu, J., G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
84. Ma, X., M. Kumar, S.N. Choudhury, L.E. Becker Buscaglia, J.R. Barker, K. Kanakamedala, M.F. Liu, and Y. Li. 2011. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci U S A 108:10144-10149.
85. Mayr, C., M.T. Hemann, and D.P. Bartel. 2007. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315:1576-1579.
86. Medina, P.P., M. Nolde, and F.J. Slack. 2010. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467:86-90.
87. Melo, S.A., S. Ropero, C. Moutinho, L.A. Aaltonen, H. Yamamoto, G.A. Calin, S. Rossi, A.F. Fernandez, F. Carneiro, C. Oliveira, B. Ferreira, C.G. Liu, et al. 2009. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41:365-370.
88. Melo, S.A., C. Moutinho, S. Ropero, G.A. Calin, S. Rossi, R. Spizzo, A.F. Fernandez, V.Davalos, A. Villanueva, G. Montoya, H. Yamamoto, S. Schwartz Jr., et al. 2010. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18:303-315.
89. Meng, F., R. Henson, M. Lang, H. Wehbe, S. Maheshwari, J.T. Mendell, J. Jiang, T.D. Schmittgen, and T. Patel. 2006. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129.
90. Meng, F., R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, and T. Patel. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-658.
91. Mott, J.L., S. Kobayashi, S.F. Bronk, and G.J. Gores. 2007. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26:6133-6140.
92. Murchison, E.P., J.F. Partridge, O.H. Tam, S. Cheloufi, and G.J. Hannon. 2005. Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci U S A 102:12135-12140.
93. Nair, V.S., L.S. Maeda, and J.P. Ioannidis. 2012. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst 104:528-540.
94. Navarro, A., A. Gaya, A. Martinez, A. Urbano-Ispizua, A. Pons, O. Balague, B. Gel, P. Abrisqueta, A. Lopez-Guillermo, R. Artells, E. Montserrat, and M. Monzo. 2008. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111:2825-2832.
95. Nicoli, S., C.P. Knyphausen, L.J. Zhu, A. Lakshmanan, and N.D. Lawson. 2012. miR-221 is required for endothelial tip cell behaviors during vascular development. Dev Cell 22:418-429.
96. O'Donnell, K.A., E.A. Wentzel, K.I. Zeller, C.V. Dang, and J.T. Mendell. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843.
97. Ota, A., H. Tagawa, S. Karnan, S. Tsuzuki, A. Karpas, S. Kira, Y. Yoshida, and M. Seto. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64:3087-3095.
98. Pasquinelli, A.E., B.J. Reinhart, F. Slack, M.Q. Martindale, M.I. Kuroda, B. Maller, D.C. Hayward, E.E. Ball, B. Degnan, P. Muller, J. Spring, A. Srinivasan, et al. 2000. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86-89.
99. Pekarsky, Y. and C.M. Croce. 2010. Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget 1:224-227.
100. Pekarsky, Y., U. Santanam, A. Cimmino, A. Palamarchuk, A. Efanov, V. Maximov, S. Volinia, H. Alder, C.G. Liu, L. Rassenti, G.A. Calin, J.P. Hagan, et al. 2006. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66:11590-11593.
101. Piskounova, E., C. Polytarchou, J.E. Thornton, R.J. LaPierre, C. Pothoulakis, J.P. Hagan, D. Iliopoulos, and R.I. Gregory. 2011. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 147:1066-1079.
102. Png, K.J., N. Halberg, M. Yoshida, and S.F. Tavazoie. 2012. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481:190-194.
103. Qiao, D., A.M. Zeeman, W. Deng, L.H. Looijenga, and H. Lin. 2002. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 21:3988-3999.
104. Reinhart, B.J., F.J. Slack, M. Basson, A.E. Pasquinelli, J.C. Bettinger, A.E. Rougvie, H.R. Horvitz, and G. Ruvkun. 2000. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906.
105. Rodriguez, A., E. Vigorito, S. Clare, M.V. Warren, P. Couttet, D.R. Soond, S. van Dongen, R.J. Grocock, P.P. Das, E.A. Miska, D. Vetrie, K. Okkenhaug, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611.
106. Sachdeva, M., S. Zhu, F. Wu, H. Wu, V. Walia, S. Kumar, R. Elble, K. Watabe, and Y.Y. Mo. 2009. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 106:3207-3212.
107. Sampson, V.B., N.H. Rong, J. Han, Q. Yang, V. Aris, P. Soteropoulos, N.J. Petrelli, S.P. Dunn, and L.J. Krueger. 2007. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67:9762-9770.
108. Santanam, U., N. Zanesi, A. Efanov, S. Costinean, A. Palamarchuk, J.P. Hagan, S. Volinia, H. Alder, L. Rassenti, T. Kipps, C.M. Croce, and Y. Pekarsky. 2010. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci U S A 107:12210-12215.
109. Schetter, A.J., S.Y. Leung, J.J. Sohn, K.A. Zanetti, E.D. Bowman, N. Yanaihara, S.T. Yuen, T.L. Chan, D.L. Kwong, G.K. Au, C.G. Liu, G.A. Calin, et al. 2008a. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425-436.
110. Schetter, A.J., S.Y. Leung, J.J. Sohn, K.A. Zanetti, E.D. Bowman, N. Yanaihara, S.T. Yuen, T.L. Chan, D.L. Kwong, G.K. Au, C.G. Liu, G.A. Calin, et al. 2008b. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425-436.
111. Shell, S., S.M. Park, A.R. Radjabi, R. Schickel, E.O. Kistner, D.A. Jewell, C. Feig, E. Lengyel, and M.E. Peter. 2007. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 104:11400-11405.
112. Si, M.L., S. Zhu, H. Wu, Z. Lu, F. Wu, and Y.Y. Mo. 2007. miR-21-mediated tumor growth. Oncogene 26:2799-2803.
113. Sinkkonen, L., T. Hugenschmidt, P. Berninger, D. Gaidatzis, F. Mohn, C.G. Artus-Revel, M. Zavolan, P. Svoboda, and W. Filipowicz. 2008. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol 15:259-267.
114. Stadler, B.M. and H. Ruohola-Baker. 2008. Small RNAs: keeping stem cells in line. Cell 132:563-566.
115. Stark, A., J. Brennecke, N. Bushati, R.B. Russell, and S.M. Cohen. 2005. Animal microRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123:1133-1146.
116. Sylvestre, Y., V. De Guire, E. Querido, U.K. Mukhopadhyay, V. Bourdeau, F. Major, G. Ferbeyre, and P. Chartrand. 2007. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282:2135-2143.
117. Takamizawa, J., H. Konishi, K. Yanagisawa, S. Tomida, H. Osada, H. Endoh, T. Harano, Y. Yatabe, M. Nagino, Y. Nimura, T. Mitsudomi, and T. Takahashi. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756.
118. Tam, W., D. Ben-Yehuda, and W.S. Hayward. 1997. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 17:1490-1502.
119. Tarasov, V., P. Jung, B. Verdoodt, D. Lodygin, A. Epanchintsev, A. Menssen, G. Meister, and H. Hermeking. 2007. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6:1586-1593.
120. Taubert, H., T. Greither, D. Kaushal, P. Wurl, M. Bache, F. Bartel, A. Kehlen, C. Lautenschlager, L. Harris, K. Kraemer, A. Meye, M. Kappler, et al. 2007. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 26:1098-1100.
121. Tazawa, H., N. Tsuchiya, M. Izumiya, and H. Nakagama. 2007. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 104:15472-15477.
122. Thai, T.H., D.P. Calado, S. Casola, K.M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J.L. Kutok, M. Schmidt-Supprian, N. Rajewsky, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316:604-608.
123. Thomson, J.M., M. Newman, J.S. Parker, E.M. Morin-Kensicki, T. Wright, and S.M. Hammond. 2006. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20:2202-2207.
124. Tian, R.Q., X.H. Wang, L.J. Hou, W.H. Jia, Q. Yang, Y.X. Li, M. Liu, X. Li, and H. Tang. 2011. MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis. J Biol Chem 286:25556-25563.
125. Trang, P., P.P. Medina, J.F. Wiggins, L. Ruffino, K. Kelnar, M. Omotola, R. Homer, D. Brown, A.G. Bader, J.B. Weidhaas, and F.J. Slack. 2009. Regression of murine lung tumors by the let-7 microRNA. Oncogene 29:1580-1587.
126. Valastyan, S., F. Reinhardt, N. Benaich, D. Calogrias, A.M. Szasz, Z.C. Wang, J.E. Brock, A.L. Richardson, and R.A. Weinberg. 2009. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032-1046.
127. Vigorito, E., K.L. Perks, C. Abreu-Goodger, S. Bunting, Z. Xiang, S. Kohlhaas, P.P. Das, E.A. Miska, A. Rodriguez, A. Bradley, K.G. Smith, C. Rada, et al. 2007. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847-859.
128. Viswanathan, S.R., G.Q. Daley, and R.I. Gregory. 2008. Selective blockade of microRNA processing by Lin28. Science 320:97-100.
129. Volinia, S., G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257-2261.
130. Voorhoeve, P.M., C. le Sage, M. Schrier, A.J. Gillis, H. Stoop, R. Nagel, Y.P. Liu, J. van Duijse, J. Drost, A. Griekspoor, E. Zlotorynski, N. Yabuta, et al. 2007. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol 604:17-46.
131. Wang, Y., R. Medvid, C. Melton, R. Jaenisch, and R. Blelloch. 2007. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 39:380-385.
132. Welch, C., Y. Chen, and R.L. Stallings. 2007. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26:5017-5022.
133. Wightman, B., I. Ha, and G. Ruvkun. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75:855-862.
134. Woods, K., J.M. Thomson, and S.M. Hammond. 2007. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282:2130-2134.
135. Xhemalce, B., S.C. Robson, and T. Kouzarides. 2012. Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell 151:278-288.
136. Xu, N., T. Papagiannakopoulos, G. Pan, J.A. Thomson, and K.S. Kosik. 2009. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137:647-658.
137. Yamagishi, M., K. Nakano, A. Miyake, T. Yamochi, Y. Kagami, A. Tsutsumi, Y. Matsuda, A. Sato-Otsubo, S. Muto, A. Utsunomiya, K. Yamaguchi, K. Uchimaru, et al. 2012. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 21:121-135.
138. Yanaihara, N., N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R.M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G.A. Calin, C.G. Liu, et al. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198.
139. Yang, M., H. Shen, C. Qiu, Y. Ni, L. Wang, W. Dong, Y. Liao, and J. Du. 2012. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer 49:604-615.
140. Yi, R., M.N. Poy, M. Stoffel, and E. Fuchs. 2008. A skin microRNA promotes differentiation by repressing "stemness". Nature 452:225-229.
141. Yu, F., H. Yao, P. Zhu, X. Zhang, Q. Pan, C. Gong, Y. Huang, X. Hu, F. Su, J. Lieberman, and E. Song. 2007. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109-1123.
142. Yu, S.L., H.Y. Chen, G.C. Chang, C.Y. Chen, H.W. Chen, S. Singh, C.L. Cheng, C.J. Yu, Y.C. Lee, H.S. Chen, T.J. Su, C.C. Chiang, et al. 2008. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48-57.
143. Zhang, T., K. Nie, and W. Tam. 2008a. BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells. Leukemia 22:1795-1797.
144. Zhang, Z., Z. Li, C. Gao, P. Chen, J. Chen, W. Liu, S. Xiao, and H. Lu. 2008b. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88:1358-1366.
145. Zhang, J., H. Guo, H. Zhang, H. Wang, G. Qian, X. Fan, A.R. Hoffman, J.F. Hu, and S. Ge. 2011. Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer 117:86-95.